These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9729004)

  • 1. Primary pulmonary hypertension.
    Gaine SP; Rubin LJ
    Lancet; 1998 Aug; 352(9129):719-25. PubMed ID: 9729004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary hypertension: Current therapy.
    Sitbon O; Humbert M; Simonneau G
    Prog Cardiovasc Dis; 2002; 45(2):115-28. PubMed ID: 12411973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary pulmonary hypertension].
    Winkler J
    Z Gesamte Inn Med; 1993 Nov; 48(11):555-62. PubMed ID: 8291274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of primary pulmonary hypertension.
    Klings ES; Farber HW
    Drugs; 2001; 61(13):1945-56. PubMed ID: 11708765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Apitz C; Hansmann G; Schranz D
    Heart; 2016 May; 102 Suppl 2():ii23-9. PubMed ID: 27053694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
    Raffy O; Azarian R; Brenot F; Parent F; Sitbon O; Petitpretz P; Hervé P; Duroux P; Dinh-Xuan AT; Simonneau G
    Circulation; 1996 Feb; 93(3):484-8. PubMed ID: 8565165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of primary pulmonary hypertension.
    De Backer TL; Smedema JP; Carlier SG
    BioDrugs; 2001; 15(12):801-17. PubMed ID: 11784212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-related pulmonary hypertension.
    Limsukon A; Saeed AI; Ramasamy V; Nalamati J; Dhuper S
    Mt Sinai J Med; 2006 Nov; 73(7):1037-44. PubMed ID: 17195895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator therapy for primary pulmonary hypertension in children.
    Barst RJ; Maislin G; Fishman AP
    Circulation; 1999 Mar; 99(9):1197-208. PubMed ID: 10069788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy of primary pulmonary hypertension.
    Nagaya N
    Am J Cardiovasc Drugs; 2004; 4(2):75-85. PubMed ID: 15049720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics.
    Abraham WT; Raynolds MV; Badesch DB; Wynne KM; Groves BM; Roden RL; Robertson AD; Lowes BD; Zisman LS; Voelkel NF; Bristow MR; Perryman MB
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):27-30. PubMed ID: 12692750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of primary pulmonary hypertension.
    Krishnan U
    Indian J Pediatr; 2000 Mar; 67(3 Suppl):S41-5. PubMed ID: 11129920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of portopulmonary hypertension.
    Tam NL; He XS
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):464-9. PubMed ID: 17897906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension and women.
    De Marco T
    Cardiol Rev; 2006; 14(6):312-8. PubMed ID: 17053380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.
    Conte JV; Gaine SP; Orens JB; Harris T; Rubin LJ
    J Heart Lung Transplant; 1998 Jul; 17(7):679-85. PubMed ID: 9703232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.